Table 2.
Glycerol addition | Time | CLC (mg per 120 × 106 spermatozoa mL–1) | ||||||
---|---|---|---|---|---|---|---|---|
0 | 0.5 | 1.5 | 3.0 | 4.5 | 6.0 | 7.5 | ||
22°C | Post-thaw | 8.3 ± 4.6b | 20.0 ± 7.5a2 | 21.1 ± 8.8a2 | 8.9 ± 5.0a2 | 6.1 ± 3.9b | 3.3 ± 1.7b | 1.7 ± 1.2b |
Dilution 0 h | 1.9 ± 0.8c | 12.1 ± 3.5b2 | 20.6 ± 4.0a2 | 3.9 ± 1.4c2 | 1.7 ± 1.1c | 0.6 ± 0.4c | 0.6 ± 0.6c | |
Dilution 1 h | 1.1 ± 0.6b2 | 10.0 ± 2.9a2 | 15.0 ± 3.3a2 | 2.2 ± 1.2b2 | 0.8 ± 0.6b | 0.3 ± 0.2b | 0.3 ± 0.3b | |
Dilution 2 h | 0 ± 0b2 | 8.1 ± 2.4a2 | 9.4 ± 3.2a2 | 1.4 ± 1.1b2 | 0.7 ± 0.6b | 0.2 ± 0.1b | 0.3 ± 0.3b | |
Dilution 3 h | 0 ± 0b | 6.4 ± 2.5a2 | 7.2 ± 2.6a2 | 0.8 ± 0.8b2 | 0.3 ± 0.3b | 0.1 ± 0.0b | 0.0 ± 0.0b | |
Dilution 4 h | 0 ± 0b | 5.3 ± 2.3a2 | 6.9 ± 2.5a2 | 0.8 ± 0.8b | 0.3 ± 0.3b | 0.0 ± 0.0b | 0.0 ± 0.0b | |
4°C | Post-thaw | 16.1 ± 6.6c | 35.0 ± 5.5ab1 | 45.0 ± 6.0a1 | 28.9 ± 4.1bc1 | 15.6 ± 3.7c | 10.6 ± 2.4c | 9.2 ± 1.4c |
Dilution 0 h | 12.4 ± 4.7cd | 29.4 ± 3.9b1 | 38.1 ± 3.5a1 | 14.7 ± 2.1c1 | 5.8 ± 2.1de | 3.8 ± 0.9e | 1.3 ± 0.6e | |
Dilution 1 h | 9.3 ± 3.7b1 | 22.2 ± 4.4a1 | 28.6 ± 3.7a1 | 9.0 ± 2.1b1 | 3.3 ± 1.3bc | 1.3 ± 0.6c | 0.6 ± 0.4c | |
Dilution 2 h | 6.9 ± 2.9c1 | 17.5 ± 3.7b1 | 23.1 ± 3.4a1 | 7.2 ± 1.6c1 | 1.8 ± 1.0cd | 0.4 ± 0.3d | 0.3 ± 0.3d | |
Dilution 3 h | 4.7 ± 2.0cd | 15.6 ± 3.5b1 | 20.8 ± 3.3a1 | 6.3 ± 1.5c1 | 1.1 ± 0.8de | 0.0 ± 0.0e | 0.0 ± 0.0e | |
Dilution 4 h | 3.2 ± 1.8b | 10.6 ± 2.7a1 | 14.4 ± 3.1a1 | 4.0 ± 1.4b | 0.6 ± 0.6b | 0.0 ± 0.0b | 0.0 ± 0.0b |
Values are the mean ± s.e.m. Values with different superscript letters among cholesterol-loaded cyclodextrin (CLC) treatments within the same time point and glycerol treatment differ significantly (P < 0.05). Values with different superscript numbers between glycerol addition temperatures, within the same time point and CLC level, differ significantly (P < 0.05). % pMOT, progressive sperm motility